United States
FDA Approves AVITA Medical's RECELL for Vitiligo Skin Repigmentation
AVITA Medical, Inc., a regenerative medicine company leading the developmen...
Pharmarack partners with Quantiphi and Snowflake to revolutionise India's pharma industry with AI
US-based Quantiphi, an artificial intelligence (AI)-first digital engineeri...
ACG and AGA Invest in Oshi Health to Boost Hybrid Digestive Health Care Adoption
Oshi Health has announced strategic investments by the American C...
Simple HealthKit Introduces Convenient At-Home Testing Kits on Walmart.com
Simple HealthKit, which provides the first human-centric, complete diagnost...
CancerVAX Announces Encouraging Advances in Pediatric Cancer Immunotherapy Treatment
CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that ...
aVaxziPen Revolutionizes Vaccine Delivery for Enhanced Accessibility and Distribution
aVaxziPen Ltd, a biotech company developing a novel needle-free vaccin...
AccuStem Sciences and University Hospitals Collaborate on Groundbreaking Research
AccuStem Sciences, Inc., a clinical stage diagnostics company dedicated to ...
Treace Medical Concepts Acquires Patient-Specific Instrumentation Technology for Foot and Ankle Surgeries
Treace Medical Concepts, Inc., a medical technology company driving a funda...
Elicio Therapeutics Successfully Merges with Angion Biomedica
Elicio Therapeutics, a clinical-stage biotechnology company developing a pi...
Telesis Bio Secures Financing of $28.0 Million
Telesis Bio Inc., a leader in molecular biology automation solutions for mu...
Palette Life Sciences Launches Barrigel Center of Excellence Program Designations
Palette Life Sciences, a fully-integrated global life sciences company dedi...
Larkspur Biosciences to Present Breakthrough Innovations at the 2023 BIO International Convention
Larkspur Biosciences is building the next precision immunotherapies to outs...
Trethera Secures $2M NCI Grant for Biomarker Advancement in Phase 1 Trial
Trethera Corporation, a clinical stage biopharmaceutical company committed ...
FDA Approves Lexicon's INPEFA (sotagliflozin) for Heart Failure
Lexicon Pharmaceuticals, Inc. today announced that the U.S. Food and Drug A...
TScan Therapeutics Successfully Prices $140 Million Public Offering
TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company focuse...
Sunstone Therapies' Psilocybin Therapy Shows Long-Term Benefits for MDD in Cancer Patients: ASCO Study
Sunstone Therapies, a leader in the development of clinical trials and the ...
Cullinan Oncology to Present First Monotherapy Clinical Data for CLN-619, a Novel Anti-MICA/B Antibody, at ASCO 2023
Cullinan Oncology, Inc., a biopharmaceutical company focused on modality-ag...
Tempest Presents Phase 1 Data on TPST-1495 in Advanced Cancers at ASCO
Tempest Therapeutics, Inc., a clinical-stage oncology company developing fi...
